Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy
Launched by POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH · May 13, 2015
Trial Information
Current as of July 07, 2025
Completed
Keywords
ClinConnect Summary
This is a prospective randomized study to assess the efficacy and safety of a single dose of cefazolin 2g IV for the prophylaxis of surgical site and pleural space infections during medical thoracoscopy.
Consecutive patients who are planned to undergo a medical thoracoscopy (rigid or semirigid) will be enrolled in the study if they satisfy the inclusion and exclusion criteria. One hundred patients will be randomized in 1:1 ratio to receive either of the following: (a) A single dose of intravenous cefazolin 2 gms dissolved in 100 mL of normal saline administered over 10 minutes, between 15 ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥12 years
- • 2. Medical thoracoscopy being performed for a pleural effusion for any of the three indications: diagnosis, pleurodesis, or adhesiolysis
- Exclusion Criteria:
- • 1. Age ≥80 years
- • 2. Pao2/FIO2\< 300;
- • 3. Hemodynamic instability
- • 4. Myocardial infarction or unstable angina in the last 6 wk
- • 5. Lack of pleural space due to adhesions
- • 6. Uncorrected coagulopathy
- • 7. Failure to provide informed consent
- • 8. Patients already taking any antibiotic due to any reason
About Post Graduate Institute Of Medical Education And Research, Chandigarh
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh is a premier institute dedicated to advancing medical education, research, and healthcare delivery in India. Renowned for its commitment to excellence, PGIMER plays a pivotal role in conducting cutting-edge clinical trials that contribute to the development of innovative therapies and improve patient outcomes. With a multidisciplinary approach and a team of highly qualified professionals, PGIMER fosters a collaborative environment for research, aiming to enhance medical knowledge and practice through rigorous scientific inquiry and evidence-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chandigarh, , India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials